Clinical Approach to Neurorheumatology

Abstract

Rheumatologic conditions are an important cause of both central and peripheral nervous system pathology. A thorough evaluation for an underlying rheumatologic process is an important component of a patient presenting with neurologic symptoms. In this review, the authors present an approach to evaluating rheumatologic conditions, focusing primarily on the history and physical examination. They focus on the most specific signs and symptoms that may help the neurologist assess whether an underlying rheumatologic process is present. In addition, they discuss the interpretation of such findings with an eye toward narrowing the differential diagnosis and directing further testing.

Keywords

rheumatology - autoimmune condition - clinical approach - vasculitis - lupus - sarcoidosis - Behçet disease

• References

• 1 Gorson KC. Vasculitic neuropathies: an update. Neurologist 2007; 13 (1) 12-19
• 2 Stone JH, Merkel PA, Spiera R , et al; RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363 (3) 221-232
• 3 Futrell N, Schultz LR, Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992; 42 (9) 1649-1657
• 4 Hoffman GS, Kerr GS, Leavitt RY , et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116 (6) 488-498
• 5 Zhou WJ, Yang CD. The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients. Lupus 2009; 18 (9) 807-812
• 6 Guillevin L, Durand-Gasselin B, Cevallos R , et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42 (3) 421-430
• 7 Kane D, Balint PV, Sturrock RD. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol 2003; 30 (5) 966-971
• 8 Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372 (9634) 234-245
• 9 Chikura B, Moore TL, Manning JB, Vail A, Herrick AL. Sparing of the thumb in Raynaud's phenomenon. Rheumatology (Oxford) 2008; 47 (2) 219-221
• 10 Kumar P, Galarrage B, Belch JJ. Raynaud's phenomenon. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, , eds. Rheumatology. 5th ed. Philadelphia: Elsevier; 2011: 1424-1432
• 11 Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988; 47 (8) 634-641
• 12 Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158 (6) 595-600
• 13 Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol 2005; 50 (4) 351-363
• 14 Rothova A, Buitenhuis HJ, Meenken C , et al. Uveitis and systemic disease. Br J Ophthalmol 1992; 76 (3) 137-141
• 15 Thorne JE, Jabs DA. Ocular manifestations of vasculitis. Rheum Dis Clin North Am 2001; 27 (4) 761-779 , vi
• 16 Bonfioli AA, Orefice F. Sarcoidosis. Semin Ophthalmol 2005; 20 (3) 177-182
• 17 Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev 2014; 13 (4-5) 550-555
• 18 Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004; 12 (2) 137-142
• 19 Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998; 125 (4) 509-520
• 20 Smetana GW, Shmerling RH. Does this patient have temporal arteritis?. JAMA 2002; 287 (1) 92-101
• 21 Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum 2014; 43 (6) 806-817
• 22 Colvin IB. Audiovestibular manifestations of sarcoidosis: a review of the literature. Laryngoscope 2006; 116 (1) 75-82
• 23 Lin C, Lin SW, Weng SF, Lin YS. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study. Audiol Neurootol 2013; 18 (2) 95-100
• 24 Agrup C, Luxon LM. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol 2006; 19 (1) 26-32
• 25 Shiboski SC, Shiboski CH, Criswell L , et al; Sjögren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64 (4) 475-487
• 26 Delalande S, de Seze J, Fauchais AL , et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83 (5) 280-291
• 27 Carruthers MN, Stone JH, Khosroshahi A. The latest on IgG4-RD: a rapidly emerging disease. Curr Opin Rheumatol 2012; 24 (1) 60-69
• 28 Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341 (17) 1284-1291
• 29 Mat MC, Goksugur N, Engin B, Yurdakul S, Yazici H. The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study. Int J Dermatol 2006; 45 (5) 554-556
• 30 Vasudevan AR, Ginzler EM. Clinical features of systemic lupus erythematosus. In Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, , eds. Rheumatology, 5th ed. Philadelphia: Elsevier; 2011: 1229-1246
• 31 Stone JH, Nousari HC. “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin. Curr Opin Rheumatol 2001; 13 (1) 23-34
• 32 Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78 (1) 26-37
• 33 Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 2009; 10 (6) 365-381
• 34 Pipitone N, Boiardi L, Olivieri I , et al. Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 2004; 22 (6) , (Suppl. 36) S46-S51
• 35 Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990; 7 (2) 113-118
• 36 Reed J, deShazo RD, Houle TT, Stringer S, Wright L, Moak III JS. Clinical features of sarcoid rhinosinusitis. Am J Med 2010; 123 (9) 856-862
• 37 Sablé-Fourtassou R, Cohen P, Mahr A , et al; French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143 (9) 632-638
• 38 Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004; 363 (9410) 717-727
• 39 Navaratnam V, Ali N, Smith CJ, McKeever T, Fogarty A, Hubbard RB. Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?. Respir Med 2011; 105 (12) 1925-1930
• 40 Corsello BF, Lohaus GH, Funahashi A. Endobronchial mass lesion due to sarcoidosis: complete resolution with corticosteroids. Thorax 1983; 38 (2) 157-158
• 41 Chirinos JA, Tamariz LJ, Lopes G , et al. Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol 2004; 23 (2) 152-159
• 42 Grayson PC, Tomasson G, Cuthbertson D , et al; Vasculitis Clinical Research Consortium. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol 2012; 39 (2) 303-309
• 43 Miyakis S, Lockshin MD, Atsumi T , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (2) 295-306
• 44 Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3 (3) 148-155
• 45 Merkel PA, Lo GH, Holbrook JT , et al; Wegener's Granulomatosis Etanercept Trial Research Group. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005; 142 (8) 620-626